Literature DB >> 29189412

Harnessing the lymph node microenvironment.

Natalie A O'Neill1, Haleigh B Eppler2, Christopher M Jewell2, Jonathan S Bromberg1.   

Abstract

PURPOSE OF REVIEW: To evaluate role of the lymph node in immune regulation and tolerance in transplantation and recent advances in the delivery of antigen and immune modulatory signals to the lymph node. RECENT
FINDINGS: Lymph nodes are a primary site of immune cell priming, activation, and modulation, and changes within the lymph node microenvironment have the potential to induce specific regulation, suppression, and potentially tolerance. Antigen enters the lymph node either from tissues via lymphatics, from blood via high endothelial venules, or directly via injection. Here we review different techniques and materials to deliver antigen to the lymph node including microparticles or nanoparticles, ex-vivo antigen presenting cell manipulation, and use of receptor conjugation for specific intralymph node targeting locations.
SUMMARY: The promising results point to powerful techniques to harness the lymph node microenvironment and direct systemic immune regulation. The materials, techniques, and approaches suggest that translational and clinical trials in nonhuman primate and patients may soon be possible.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29189412      PMCID: PMC6309445          DOI: 10.1097/MOT.0000000000000488

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  106 in total

Review 1.  T-cell function and migration. Two sides of the same coin.

Authors:  U H von Andrian; C R Mackay
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

Review 2.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

3.  Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.

Authors:  Susan R Schwab; João P Pereira; Mehrdad Matloubian; Ying Xu; Yong Huang; Jason G Cyster
Journal:  Science       Date:  2005-09-09       Impact factor: 47.728

4.  Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection.

Authors:  Olivier Preynat-Seauve; Prisca Schuler; Emmanuel Contassot; Friedrich Beermann; Bertrand Huard; Lars E French
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

5.  Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility.

Authors:  J P Hobson; H M Rosenfeldt; L S Barak; A Olivera; S Poulton; M G Caron; S Milstien; S Spiegel
Journal:  Science       Date:  2001-03-02       Impact factor: 47.728

6.  Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells.

Authors:  Jordi C Ochando; Adam C Yopp; Yu Yang; Alexandre Garin; Yansui Li; Peter Boros; Jaime Llodra; Yaozhong Ding; Sergio A Lira; Nancy R Krieger; Jonathan S Bromberg
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Leukemia inhibitory factor is linked to regulatory transplantation tolerance.

Authors:  Su M Metcalfe; Tracy J Watson; Sandra Shurey; Elizabeth Adams; Colin J Green
Journal:  Transplantation       Date:  2005-03-27       Impact factor: 4.939

8.  CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.

Authors:  Lawrence R Shiow; David B Rosen; Nadezda Brdicková; Ying Xu; Jinping An; Lewis L Lanier; Jason G Cyster; Mehrdad Matloubian
Journal:  Nature       Date:  2006-03-08       Impact factor: 49.962

9.  Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes.

Authors:  Tomoya Katakai; Takahiro Hara; Manabu Sugai; Hiroyuki Gonda; Akira Shimizu
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

10.  Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes.

Authors:  Mark J Miller; Olga Safrina; Ian Parker; Michael D Cahalan
Journal:  J Exp Med       Date:  2004-10-04       Impact factor: 14.307

View more
  4 in total

Review 1.  Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines.

Authors:  Geoffrey M Lynn; Richard Laga; Christopher M Jewell
Journal:  Cancer Lett       Date:  2019-06-08       Impact factor: 8.679

2.  The Lymph Node Microenvironment May Invigorate Cancer Cells With Enhanced Metastatic Capacities.

Authors:  Tianhang Li; Tianyao Liu; Zihan Zhao; Xinyan Xu; Shoubin Zhan; Shengkai Zhou; Ning Jiang; Wenjie Zhu; Rui Sun; Fayun Wei; Baofu Feng; Hongqian Guo; Rong Yang
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

3.  Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes.

Authors:  Yen-Liang Li; Chung-Hsing Chen; Jing-Yi Chen; You-Syuan Lai; Shao-Chun Wang; Shih-Sheng Jiang; Wen-Chun Hung
Journal:  Oncoimmunology       Date:  2020-10-19       Impact factor: 8.110

4.  Characterization of Leptin Receptor+ Stromal Cells in Lymph Node.

Authors:  Liwei Jiang; Mine Yilmaz; Mayuko Uehara; Cecilia B Cavazzoni; Vivek Kasinath; Jing Zhao; Said Movahedi Naini; Xiaofei Li; Naima Banouni; Paolo Fiorina; Su Ryon Shin; Stefan G Tullius; Jonathan S Bromberg; Peter T Sage; Reza Abdi
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.